Christoph Mamot
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 12
-
- Monoclonal and Polyclonal Antibodies Research 13
- Radiomics and Machine Learning in Medical Imaging 4
- Genetics top 5%
- Oncology top 5%
- HER2/EGFR in Cancer Research 9
- CAR-T cell therapy research 4
-
- Lymphoma Diagnosis and Treatment 14
-
- Lung Cancer Treatments and Mutations 6
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- John W. ParkDaryl C. DrummondDmitri B. KirpotinKeelung HongCharles O. NobleChristoph RochlitzReto RitschardJames D. Marks
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Christoph Mamot
46 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 92
- Biomaterials 958
- Radiology, Nuclear Medicine and Imaging 570
- Genetics 233
- Oncology 578
- Pathology and Forensic Medicine 353
Countries citing papers authored by Christoph Mamot
This map shows the geographic impact of Christoph Mamot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Mamot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Mamot more than expected).
Fields of papers citing papers by Christoph Mamot
This network shows the impact of papers produced by Christoph Mamot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Mamot. The network helps show where Christoph Mamot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christoph Mamot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2021 | 20 | |
| 3 | 2021 | 4 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 16 | |
| 6 | 2020 | 57 | |
| 7 | 2019 | 7 | |
| 8 | 2017 | 19 | |
| 9 | 2015 | 18 | |
| 10 | 2015 | 31 | |
| 11 | 2015 | 5 | |
| 12 | 2014 | 4 | |
| 13 | 2011 | 77 | |
| 14 | 2011 | 54 | |
| 15 | 2006 | 14 | |
| 16 | 2004 | 110 | |
| 17 | 2004 | 119 | |
| 18 | 2003 | 135 | |
| 19 | 2003 | 17 | |
| 20 | 1995 | 1 |
About Christoph Mamot
Christoph Mamot is a scholar working on Microbiology, Biomaterials and Oncology, having authored 49 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Nanoparticle-Based Drug Delivery (12 papers), HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), CAR-T cell therapy research (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Biomaterials (958 citations), Radiology, Nuclear Medicine and Imaging (570 citations) and Genetics (233 citations). Christoph Mamot has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include John W. Park, Daryl C. Drummond, Dmitri B. Kirpotin, Keelung Hong, Charles O. Noble, Christoph Rochlitz, Reto Ritschard, James D. Marks, Richard Herrmann and Andreas Wicki. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.